Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Targeted Therapy”

2,678 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,678 results

Not applicableNot Yet RecruitingNCT07327515
What this trial is testing

PET/CT-Guided Biological Target Volume Delineation and Dose Optimization for Radioactive Seed Implantation Therapy in Malignant Tumors

Who this might be right for
Malignant Tumors
Li Min 90
Not applicableStudy completedNCT02958176
What this trial is testing

Heart Rate Variability Biofeedback for Female Sexual Arousal Disorder

Who this might be right for
Female Sexual Arousal Disorder
University of Texas at Austin 65
Not applicableUnknownNCT01504113
What this trial is testing

The Impact of Targeted Therapy on Microorganism in Patients With Psoriasis

Who this might be right for
Psoriasis
National Taiwan University Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT06918990
What this trial is testing

Treatment of Antibody-Mediated Rejection (ABMR) With CarBel

Who this might be right for
Kidney Transplant Rejection
National Institute of Allergy and Infectious Diseases (NIAID) 100
Not applicableUnknownNCT02242552
What this trial is testing

Personalized Targeted Therapy in Refractory or Relapsed Cancer in Childhood

Who this might be right for
Pediatric Cancer
St. Justine's Hospital 30
Large-scale testing (Phase 3)Looking for participantsNCT06227910
What this trial is testing

Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease

Who this might be right for
Crohn's Disease
Takeda 396
Large-scale testing (Phase 3)Study completedNCT00525291
What this trial is testing

Triple Target Treatment (3T) Which Combines Stimulation With Amplitude Modulated Middle Frequency (AM-MF), Electromyography (EMG)-Triggered Stimulation and EMG-Biofeedback Compared With EMG-Biofeedback in Anal Incontinence

Who this might be right for
Fecal Incontinence
University of Giessen 158
Not applicableNot Yet RecruitingNCT06412718
What this trial is testing

Validation of Human Drugs Target of Repurposed Drugs and Novel Therapies

Who this might be right for
Rare DiseasesAniridiaNeurotrophic Keratopathy+5 more
IRCCS Ospedale San Raffaele 274
Testing effectiveness (Phase 2)Study completedNCT01271725
What this trial is testing

LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures

Who this might be right for
Breast Neoplasms
Boehringer Ingelheim 74
Testing effectiveness (Phase 2)WithdrawnNCT03818997
What this trial is testing

Combination of Targeted and Immunotherapy for Advanced Biliary Tract and Esophagogastric Gastric Cancer

Who this might be right for
Esophageal CancerBiliary Tract CancerGastroEsophageal Cancer+1 more
European Organisation for Research and Treatment of Cancer - EORTC
Not applicableStudy completedNCT03411148
What this trial is testing

Targeting Balance Confidence to Increase Community Integration in Users of Prostheses

Who this might be right for
AmputationPhysical Activity
Rosalind Franklin University of Medicine and Science 22
Not applicableStudy completedNCT05225740
What this trial is testing

Exposure Therapy Consortium (ETC) for Anxiety Sensitivity

Who this might be right for
Elevated Anxiety Sensitivity
University of Texas at Austin 399
Early research (Phase 1)Active Not RecruitingNCT04555551
What this trial is testing

MCARH109 Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of Multiple Myeloma

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 17
Early research (Phase 1)UnknownNCT05420545
What this trial is testing

A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

Who this might be right for
Metastatic TumorAdvanced Solid TumorRenal Cell Carcinoma+2 more
Chongqing Precision Biotech Co., Ltd 36
Early research (Phase 1)UnknownNCT04887012
What this trial is testing

Clinical Study of HLA Haploidentical CAR-NK Cells Targeting CD19 in the Treatment of Refractory/Relapsed B-cell NHL

Who this might be right for
B-cell Non Hodgkin Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University 25
Testing effectiveness (Phase 2)Study completedNCT02280811
What this trial is testing

T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers

Who this might be right for
Vaginal CancerCervical CancerAnal Cancer+2 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Study completedNCT00922584
What this trial is testing

Sorafenib Treatment in Non-Small Cell Lung Cancer After Failure of Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor

Who this might be right for
Non-Small Cell Lung Cancer
Chinese Society of Lung Cancer 65
Not applicableLooking for participantsNCT06796543
What this trial is testing

Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma

Who this might be right for
Metastatic SarcomaRadiation Therapy PatientEwing Sarcoma+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 70
Not applicableStudy completedNCT02688868
What this trial is testing

Evaluation of New Specifications (2.25mm) of FirehawkTM in the Treatment of Coronary Heart Disease ( Firehawk_2.25 )

Who this might be right for
Coronary Heart Disease
Shanghai MicroPort Medical (Group) Co., Ltd. 38
Not applicableUnknownNCT02857699
What this trial is testing

Prospective Observational Study to Investigate the Added Value of the Health Related Quality of Life and Patient Reported Symptoms in the Identification of the Recommended Phase II Dose in Phase I Trials of Molecularly Targeted Therapies.

Who this might be right for
Solid TumorsQuality of Life
Institut Curie 250
Load More Results